Georgia Keresty - 23 Jun 2021 Form 4/A - Amendment Insider Report for Intellia Therapeutics, Inc. (NTLA)

Role
Director
Signature
/s/James Basta, Attorney-In-Fact
Issuer symbol
NTLA
Transactions as of
23 Jun 2021
Net transactions value
$0
Form type
4/A - Amendment
Filing time
14 Apr 2022, 20:44:38 UTC
Date Of Original Report
25 Jun 2021
Next filing
03 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTLA Common Stock Award $0 +1,569 +32% $0.000000 6,524 23 Jun 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NTLA Stock Option (right to buy) Award $0 +2,534 $0.000000 2,534 23 Jun 2021 Common Stock 2,534 $83.59 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.
F2 This option was granted on June 23, 2021 with respect to 2,534 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant.

Remarks:

The Form 4/A amends and restates the original Form 4 filed on June 25, 2021 to correct the number of shares of common stock and stock options granted to the reporting person.